A clinical study to see the effect of some Ayurvedic formulation in the treatment of Kaphaja Timira with reference to Senile Immature Cataract.

Role of Kokilavarti Anjana in Kaphaja Timira

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013749

Enrollment

Registered

2018-05-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: Kokilavarti Anjana: Combination of fine powdered drugs including Triphala, Trikatu, Saindhav, Loha Bhasma and Daruharidra. Dose-2 shalakas dipped in Anjana formulation. Frequency-Twice

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from symptoms of Kaphaja Timira and Visual Acuity of 6/12 or less.

Exclusion criteria

Exclusion criteria: Visual Acuity less than 6/60. Complicated or traumatic Cataract, or any ocular pathology that can cause diminution of vision. Senile Mature or Hypermature Cataract.

Design outcomes

Primary

Measure	Time frame
Effect of Kokilavarti Anjana in Kaphaja TimiraTimepoint: The drug will be given for 45 days. The patients will be assessed before and after treatment. Total duration of the study will be 12 months.	—

Secondary

Measure	Time frame
Delay in Maturity of Senile Immature CataractTimepoint: 18 months	—

Countries

India

Contacts

Public ContactVd Pravin Madhukar Bhat

Sumatibhai Shah Ayurved Mahavidyalaya

vdpravin82@gmail.com9860233173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026